The adjustment is attributed to the potential impact of increased competition on the company's former top product, Indocin. Despite challenges, Assertio has successfully defended its market share ...

The company has managed to preserve its market share with Indocin, maintaining robust gross margins above 90%. Additionally, the recent financial results showed a better-than-expected bottom line ...